What is the Xtant Medical Holdings Inc. stock price forecast?

Xtant Medical Holdings Inc. is currently trading at $0.45. View real-time AI analysis on Alpha Lenz.

What is Xtant Medical Holdings Inc. insider trading activity?

View the latest insider trading data for Xtant Medical Holdings Inc. on Alpha Lenz.

What is Xtant Medical Holdings Inc.'s P/E ratio?

Xtant Medical Holdings Inc.'s P/E ratio is 12.6.

Xtant Medical Holdings Inc.

NYSE · XTNT

$0.45+0.00(+0.00%)Pre-market

Ask about Xtant Medical Holdings Inc.'s future dividend policy...

Alpha Chat Insight

“Xtant Medical Holdings Inc. trades at a P/E of 12.6 (undervalued) with solid ROE of 10.6%. 3Y revenue CAGR of 32.2% highlights clear growth momentum.”

Ask for details →

Company Overview

Xtant Medical Holdings Inc. is a leading company in the medical device sector, specializing in the development and distribution of regenerative medicine products and surgical implants. The core purpose of the company is to improve patient outcomes through innovative solutions in orthopedic and neurological surgery. Xtant Medical’s product offerings include biologics and other advanced materials designed to support the healing and repair of tissue, primarily within the spine and broader orthopedics market. Their products are integral in the treatment of complex injuries and conditions, playing a crucial role in both surgical intervention and recovery processes. Based in the healthcare industry, Xtant Medical Holdings Inc. serves hospitals, surgical centers, and clinics, providing essential tools for managing patient care. In the financial market, Xtant's products and innovations position the company as a critical provider within the medical technology landscape, underlining its market presence and influence in advancing medical treatments.

CEOMr. Sean E. Browne

Websitehttps://xtantmedical.com

SectorHealthcare

IndustryMedical Devices

Employees217

Company Statistics

FY 2025

Profile

$62.79MMarket Cap

$133.93MRevenue

0.00Shares Out

217Employees

Margins

62.92%Gross

9.46%EBITDA

5.44%Operating

5.23%Pre-Tax

3.71%Net

Valuation

12.63P/E

1.23P/B

0.47EV/Sales

5.87EV/EBITDA

6.18P/FCF

Growth (CAGR)

32.20%Rev 3Yr

20.22%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

5.29%ROA

10.59%ROE

11.35%ROIC

Financial Health

$17.05MCash & Cash Equivalents

$26.14MNet Debt

84.77%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Xtant Medical Holdings Inc. trades at a P/E of 12.6 (undervalued) with solid ROE of 10.6%. 3Y revenue CAGR of 32.2% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Xtant Medical Holdings Inc. (ticker: XTNT) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 217 employees. Market cap is $63M.

The current price is $0.45 with a P/E ratio of 12.63x and P/B of 1.23x.

ROE is 10.59% and operating margin is 5.44%. Annual revenue is $134M.